Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$21,706,214
+$3,586,253 QoQ
Shares Held
86,259
+3.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#582
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWA Asset Management Group, LLC holds $104,319,210 across 14 Drug Manufacturers - General names. ABBV ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
97,695 | $24,811,599 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
86,259 | $21,706,214 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
179,351 | $10,334,204 | |
| 4 | LLY |
ELI LILLY & Co
|
7,425 | $8,905,768 | |
| 5 | BIIB |
Biogen Inc.
|
38,127 | $8,237,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,399 | $8,009,829 | |
| 7 | MRK |
Merck & Co., Inc.
|
38,429 | $4,938,126 | |
| 8 | NVS |
Novartis AG
|
29,083 | $4,557,887 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,706,214 | 86,259 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $18,119,961 | 83,314 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $19,102,677 | 83,604 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $16,587,525 | 71,640 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $9,536,413 | 51,376 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $10,393,239 | 49,605 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $8,597,659 | 48,383 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $10,989,959 | 55,651 | Shares | Sole | 2024-11-01 | |
| 2024-03-31 | $7,692,450 | 42,243 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,154,633 | 39,715 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,012,844 | 26,921 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,520,360 | 26,129 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $3,985,365 | 25,007 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $3,892,215 | 24,084 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $3,162,927 | 23,567 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,629,126 | 23,695 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $3,847,032 | 23,731 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,321,091 | 24,528 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,541,201 | 23,558 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,491,033 | 22,115 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,430,837 | 22,462 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,373,479 | 22,151 | Shares | Sole | 2021-02-23 | |
| 2020-09-30 | $2,019,562 | 23,057 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,163,138 | 11,847 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,876,178 | 24,625 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||